Codiak BioSciences to Present at the 4th Annual Evercore ISI HealthCONx Conference

NEXT STORY
Rubius Therapeutics to Host Virtual Preclinical Pipeline and Platform Technology Day on December 16, 2021
PREV STORY
Revelation Biosciences Inc. Announces Initiation of a Phase 2b Study to Assess Efficacy of Intranasal REVTx-99 for The Prevention of H3N2 Influenza
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study

author_avatar
NASDAQ Market News

Principia Biopharma to Present at 8th Annual SVB Leerink Global Healthcare Conference

author_avatar
NASDAQ Market News

HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China

author_avatar
NASDAQ Market News